NO970545D0 - Makrofagavledet kjemokin og kjemokinanaloger - Google Patents

Makrofagavledet kjemokin og kjemokinanaloger

Info

Publication number
NO970545D0
NO970545D0 NO970545A NO970545A NO970545D0 NO 970545 D0 NO970545 D0 NO 970545D0 NO 970545 A NO970545 A NO 970545A NO 970545 A NO970545 A NO 970545A NO 970545 D0 NO970545 D0 NO 970545D0
Authority
NO
Norway
Prior art keywords
chemokine
macrophage
analogues
derived
derived chemokine
Prior art date
Application number
NO970545A
Other languages
English (en)
Other versions
NO970545L (no
Inventor
Ronald Godiska
Patrick W Gray
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/479,620 external-priority patent/US6790947B1/en
Application filed by Icos Corp filed Critical Icos Corp
Publication of NO970545D0 publication Critical patent/NO970545D0/no
Publication of NO970545L publication Critical patent/NO970545L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO970545A 1995-06-07 1997-02-06 Makrofagavledet kjemokin og kjemokinanaloger NO970545L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/479,620 US6790947B1 (en) 1995-06-07 1995-06-07 Polynucleotides encoding macrophage derived chemokine
US55865895A 1995-11-16 1995-11-16
PCT/US1996/010114 WO1996040923A1 (en) 1995-06-07 1996-06-07 Macrophage derived chemokine and chemokine analogs

Publications (2)

Publication Number Publication Date
NO970545D0 true NO970545D0 (no) 1997-02-06
NO970545L NO970545L (no) 1997-04-07

Family

ID=27046294

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970545A NO970545L (no) 1995-06-07 1997-02-06 Makrofagavledet kjemokin og kjemokinanaloger

Country Status (14)

Country Link
US (1) US5932703A (no)
EP (1) EP0778892A1 (no)
JP (1) JPH10507646A (no)
AU (1) AU708743B2 (no)
BR (1) BR9606437A (no)
CA (1) CA2196691A1 (no)
CZ (1) CZ29397A3 (no)
FI (1) FI970502A (no)
HU (1) HUP9701282A3 (no)
IL (1) IL120096A0 (no)
NO (1) NO970545L (no)
PL (1) PL318594A1 (no)
SK (1) SK16497A3 (no)
WO (1) WO1996040923A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6498015B1 (en) 1995-06-07 2002-12-24 Icos Corporation Methods of identifying agents that modulate the binding between MDC and an MDC receptor
US7018627B1 (en) 1995-06-07 2006-03-28 Icos Corporation Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
US6737513B1 (en) 1996-06-07 2004-05-18 Icos Corporation Macrophage derived chemokine (MDC) and chemokine analogs and assay to identify modulators of MDC activity, and therapeutic uses for same
WO1997025427A1 (en) * 1996-01-12 1997-07-17 Genetics Institute, Inc. Beta-chemokine, h1305 (mcp-2)
WO1998011226A2 (en) * 1996-09-10 1998-03-19 Schering Corporation Mammalian chemokines, related reagents
WO1998024907A1 (en) * 1996-12-03 1998-06-11 Amgen Inc. Novel protein with chemokine activity
AU5383498A (en) * 1996-12-05 1998-06-29 Human Genome Sciences, Inc. Human chemokine beta-13
WO1998042836A1 (en) * 1997-03-21 1998-10-01 Zymogenetics, Inc. Mammalian cytokine receptor
US6548631B1 (en) * 1997-09-16 2003-04-15 BIOMéRIEUX, INC. Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection
WO1999029728A1 (en) * 1997-12-11 1999-06-17 University Of Maryland Biotechnology Institute Method and composition to enhance the efficacy of a vaccine using chemokines
US6093542A (en) * 1998-01-09 2000-07-25 Akzo Nobel N.V. Isothermal transcription based amplification assay for the detection and quantitation of macrophage derived chemokine RNA
US7384641B2 (en) 2000-06-12 2008-06-10 University Of Maryland Biotechnology Institute Immuno-modulating effects of chemokines in DNA vaccination
US7708983B2 (en) 1998-12-11 2010-05-04 Alfredo Garzino-Demo Directional induction of immune response by co-administration of antigens with chemokines
US6245332B1 (en) * 1999-01-15 2001-06-12 The Board Of Trustees Of The Leland Stanford Junior University Modulation of systemic memory T cell trafficking
US6488930B1 (en) * 1999-01-15 2002-12-03 Millennium Pharmaceuticals, Inc. Anti-CCR4 antibodies and methods of use therefor
CA2704600C (en) 1999-04-09 2016-10-25 Kyowa Hakko Kirin Co., Ltd. A method for producing antibodies with increased adcc activity
WO2001060406A1 (en) * 2000-02-18 2001-08-23 Millennium Pharmaceuticals, Inc. Therapeutic methods that target fractalkine or cx3cr1
WO2001064754A1 (fr) * 2000-03-03 2001-09-07 Kyowa Hakko Kogyo Co., Ltd. Anticorps a recombinaison genique et son fragment
US6946292B2 (en) * 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US20020111290A1 (en) * 2000-12-01 2002-08-15 Bernhard Homey Uses of mammalian genes and related reagents
JPWO2003084569A1 (ja) 2002-04-09 2005-08-11 協和醗酵工業株式会社 抗体組成物含有医薬
MX2008002101A (es) * 2005-08-12 2008-04-19 Schering Corp Fusiones de la proteina-1 quimiotactica de monocito.
WO2008045461A2 (en) * 2006-10-11 2008-04-17 Oregon Health & Science University Transdermal diethylstilbestrol for treating prostate cancer
US8524217B2 (en) 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants
US11298413B2 (en) 2015-09-16 2022-04-12 Io Biotech Aps Vaccine compositions comprising C—C motif chemokine 22 (CCL22) or fragments thereof
JP6976566B2 (ja) 2015-10-14 2021-12-08 日本全薬工業株式会社 イヌアトピー性皮膚炎の治療及び診断のために用いる抗イヌｔａｒｃ抗体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037630A (en) * 1985-01-14 1991-08-06 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4965392A (en) * 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
JP3022566B2 (ja) * 1987-10-02 2000-03-21 ザ ロックフェラー ユニバーシティ 大食細胞誘導炎症性神経細胞
US5212073A (en) * 1989-05-12 1993-05-18 Genetics Institute, Inc. Process for producing human JE cytokine
US5179078A (en) * 1989-05-12 1993-01-12 Dana Farber Cancer Institute Method of suppressing tumor formation in vivo
US5241049A (en) * 1989-12-22 1993-08-31 Zymogenetics, Inc. Neutrophil chemoattractants
US5413778A (en) * 1992-10-05 1995-05-09 The Regents Of The University Of Michigan Labelled monocyte chemoattractant protein material and medical uses thereof
US5459128A (en) * 1993-11-12 1995-10-17 Dana-Farber Cancer Institute Human monocyte chemoattractant protein-1 (MCP-1) derivatives
EP0735818B1 (en) * 1993-12-22 2004-03-31 Human Genome Sciences, Inc. MACROPHAGE INFLAMMATORY PROTEINS MIP-3, MIP-4 AND MIP-1gamma

Also Published As

Publication number Publication date
BR9606437A (pt) 1997-09-30
AU6172496A (en) 1996-12-30
HUP9701282A3 (en) 1999-09-28
HUP9701282A2 (en) 1997-10-28
SK16497A3 (en) 1998-05-06
CZ29397A3 (cs) 1998-01-14
NO970545L (no) 1997-04-07
IL120096A0 (en) 1997-04-15
EP0778892A1 (en) 1997-06-18
FI970502A (fi) 1997-04-04
WO1996040923A1 (en) 1996-12-19
US5932703A (en) 1999-08-03
CA2196691A1 (en) 1996-12-19
JPH10507646A (ja) 1998-07-28
FI970502A0 (fi) 1997-02-06
PL318594A1 (en) 1997-06-23
AU708743B2 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
NO970545L (no) Makrofagavledet kjemokin og kjemokinanaloger
BR9609939A (pt) Despropagador adaptável
DE69607979D1 (de) GEBETSZEIT- und -RICHTUNGSBESTIMMUNGSSYSTEM
ATE192525T1 (de) Plattenförmiges bauelement
NO953895L (no) Tale-prosessering
DE69413098D1 (de) Lautsprecherstruktur
DE69614814T2 (de) Alpha-Olefinpolymerizationskatalysatoren
NO954911L (no) Tastatur for telefoner og lignende
FI933378A0 (fi) Kirjekuori
NO972103D0 (no) Eleutherobin og analoger av denne
DE69432277D1 (de) Tongerät
KR960029575U (ko) 미아 및 물품분실 방지장치
GB2300832B (en) Timber processing
KR950008806U (ko) 빠렛드
KR940021883U (ko) 우편함
KR970001650U (ko) 편지봉투
KR970009578U (ko) 편지봉투
KR970013578U (ko) 봉투
DK40596A (da) Depalleteringsanordning
UA683S (uk) Акустична система
UA682S (uk) Акустична система
KR950008817U (ko) 봉투
KR940024721U (ko) 자료봉투
FI2279U1 (fi) Postilaatikko
SE9500420D0 (sv) Brevlåda

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application